News & Media

Median Technologies to participate in the 2022 ESMO Congress, Sep 9 – 13, 2022, Paris, France, with two scientific posters on iCRO and iBiopsy®

6 September 2022, Sophia-Antipolis, France

Press release – For immediate release – 5:45 pm CEST

Median Technologies to participate in the 2022 ESMO Congress, Sep 9 – 13, 2022, Paris, France, with two scientific posters on iCRO and iBiopsy®

  • iCRO: scientific poster presentation on Sep 10, 2022: “Challenges to Assess Bone Metastases in Blinded Independent Central Review (BICR) of Breast Cancer Trials Using RECIST 1.1”
  • iBiopsy®: scientific poster presentation on Sep 11, 2022: “Artificial Intelligence Supporting Lung Cancer Screening: Computer Aided Diagnosis of Lung Lesions Driven by Morphological Feature Extraction”
  • The team will be available at Booth #447, Exhibition Hall 7.2 during the entire industry exhibition duration

Median Technologies (ALMDT) announced today that the Company will be participating in the 2022 ESMO (European Society for Medical Oncology) Congress, to be held in Paris, France, September 9-13 (venue: Paris Expo Porte de Versailles).

The Company will present two scientific posters. Details of the sessions include:

255P – Challenges to Assess Bone Metastases in Blinded Independent Central Review (BICR) of Breast Cancer Trials Using RECIST 1.1

  • Session: Breast Cancer, Metastatic
  • Date: Sep 10, 2022
  • Timeslot to meet the scientific team: 12:00 pm – 1:00 pm CEST
  • Place: Poster Area, Hall 4

919P – Artificial Intelligence Supporting Lung Cancer Screening: Computer Aided Diagnosis of Lung Lesions Driven by Morphological Feature Extraction

  • Session: New Diagnostic Tools
  • Date: Sep 11, 2022
  • Timeslot to meet the scientific team: 12:00 pm – 1:00 pm CEST
  • Place: Poster Area, Hall 4

During the industry exhibition, Median team will be available at booth #447, Hall 7.2 to discuss the scientific posters, present the latest developments on iBiopsy® LCS CADe/CADx SaMD as well as the Company’s iCRO services for image management in oncology trials including Imaging Lab, intelligent imaging capabilities for drug development. Daily presentation sessions on Imaging Lab are planned at 3:00 pm CEST at booth.

More about the ESMO congress: https://www.esmo.org/meetings/esmo-congress-2022